Latest Breaking News On - சைகடெலிக் ஸ்டாக் குறியீட்டு - Page 1 : vimarsana.com
Want to buy drugs? How ETFs offer exposure to cannabis and psychedelics
citywireselector.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from citywireselector.com Daily Mail and Mail on Sunday newspapers.
Seelos Therapeutics (NASDAQ: SEEL)Penny Stocks To Watch With Strong Leadership: Havn Life Sciences (OTC: HAVLF)
I mentioned that some of the former trailblazers of cannabis got involved in psychedelics. Havn is one of the companies that fit the mold. While its management team comprises financial markets professionals like CEO Tim Moore and Eli Dusenbury, its makeup also includes names that were part of the early cannabis boom. For instance, Gary Long, its Chief Scientific Officer, was the former CSO at Aphria Inc. (NASDAQ: APHA)
Youâve also got the former CEO of Aphria, Vic Neufeld sitting as the Executive Chairman of Havn. Under his direction, Aphria became one of the top names in cannabis just as the industry was getting off the ground. Now these same people are getting behind the psychedelic boom and have chosen to take positions with Havn to do so.
David George-Cosh, BNN Bloomberg An employee holds a tray of Aurora Cannabis Inc. Drift brand edibles inside the Hobo Cannabis Co. store in Ottawa, Ontario, Canada, on Thursday, Jan. 30, 2020. Bloomberg/David Kawai
Aurora Cannabis says bought deal offers âmaximum flexibilityâ in U.S. push
The time was right for Aurora Cannabis Inc. to strike with yet another bought deal last week. The cannabis company looked to take advantage of a recent run in its stock amid a broad investor move into cannabis at the beginning of the year.
The net result is an additional US$137 million in proceeds to Aurora s balance sheet, albeit with some additional dilution to the company s stock. While some shareholders may be growing tired of Aurora s equity moves, the additional capital will give the company some more flexibility when looking south of the border for additional deals, its chief executive officer told BNN Bloomberg. One analyst estimated the m
MINDCURE Included in First Psychedelic ETF & North American Psychedelics Index
News provided by
Share this article
Share this article
Mind Cure among respected life science and therapeutic technology peers in first ever Psychedelic ETF & North American Psychedelic Index
VANCOUVER, BC, Jan. 21, 2021 /PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ( MINDCURE or the Company ) is pleased to announce its inclusion among 17 psychedelic companies in the first ever Psychedelic ETF. Horizon s Psychedelic ETF, is expected to commence trading Jan. 26, 2021 under ticker PSYK on the NEO exchange.
The ETF includes companies in the Canadian legal psychedelics industry, as well as U.S. companies engaged in legal activities involving psychedelic drugs and substances. The purpose of the ETF is to invest in, and indirectly derive revenues from, companies in the psychedelics industry engaged in legal activities involving psychedelic drugs and substances.
vimarsana © 2020. All Rights Reserved.